Jonathan Sebat is professor of psychiatry and cellular and molecular medicine at the University of California, San Diego, and chief of the Beyster Center for Molecular Genomics of Neuropsychiatric Diseases. He investigates the molecular basis of neuropsychiatric disorders such as autism and schizophrenia.
Jonathan Sebat
Professor
University of California, San Diego
From this contributor
Why I want to march for science
Autism researcher Jonathan Sebat plans to push for policies that rest on empirical evidence and serve the common good.
Explore more from The Transmitter
After NINDS director ouster, 40 neuroscience organizations press U.S. Congress for oversight over hiring process
A letter signed by the groups asks Congress to ensure that scientific expertise remains a priority in the search for a new director of the National Institute of Neurological Disorders and Stroke.
After NINDS director ouster, 40 neuroscience organizations press U.S. Congress for oversight over hiring process
A letter signed by the groups asks Congress to ensure that scientific expertise remains a priority in the search for a new director of the National Institute of Neurological Disorders and Stroke.
By
Angie Voyles Askham
23 January 2026 | 3 min read
BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding
But whether the initiative’s road map for the next decade is feasible remains an open question.
BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding
But whether the initiative’s road map for the next decade is feasible remains an open question.
By
Claudia López Lloreda
23 January 2026 | 6 min read
Neuroscience, BRAIN Initiative gain budget in ‘bad’ NIH funding bill
The bill goes before the House of Representatives today and outlines increases for neuroscience-related research—including a 33 percent increase to the BRAIN Initiative—but maintains a multiyear spending approach that could limit the number of grants awarded overall.
Neuroscience, BRAIN Initiative gain budget in ‘bad’ NIH funding bill
The bill goes before the House of Representatives today and outlines increases for neuroscience-related research—including a 33 percent increase to the BRAIN Initiative—but maintains a multiyear spending approach that could limit the number of grants awarded overall.
By
Angie Voyles Askham
22 January 2026 | 4 min read